Navigation Links
US Oncology Applauds Journal of Clinical Oncology Study Highlighting Value of PET Scans for Cancer Patients With Various Types of Malignancies
Date:5/1/2008

National Oncologic PET Registry (NOPR) Study Showcases the Need to Expand Use of PET Technologies in Driving More Effective Cancer Treatment

WASHINGTON, May 1 /PRNewswire-USNewswire/ -- US Oncology, which supports one of the nation's largest cancer treatment and research networks representing approximately 1,200 oncologists nationwide, applauded a national study appearing in today's Journal of Clinical Oncology (JCO) that demonstrates the value of positron emission tomography (PET) scans for treating patients with ovarian, prostate, pancreatic and other types of cancers.

PET scans are commonly used for the diagnosis, staging and restaging of cancers as well as the monitoring of tumor response to treatment for Medicare patients with nine types of cancers covered by the Centers for Medicare and Medicaid Services (CMS): breast, cervical, colorectal, esophageal, head and neck, non-small-cell lung, thyroid, lymphoma and melanoma. By providing images of cancerous changes at the molecular level, PET scans for these types of cancers have given physicians the ability to detect developments that can be undetectable with routine medical imaging and have become a powerful tool in fighting cancer.

CMS's Coverage with Evidence Development (CED) policy helps it determine its Medicare coverage policies for select promising technologies; the National Oncologic PET Registry (NOPR) was developed in 2005 to meet CED coverage requirements for PET scans and to assess how fluorodeoxyglucose (FDG)-PET affects patient care. The JCO study, which reports the first-year NOPR results on the impact of PET scans on patients with noncovered cancers, showed that PET resulted in a 36.5 percent change in treatment decisions for these patients -- and that the impact of PET seems to be greater than the impact of body computed tomography (CT) scanning when it was introduced 30 years ago.

"The NOPR project itself represents a new benchmark for cooperation between CMS and the medical imaging community to help determine the value of new imaging technologies and their impact on patient management," said Dr. Landis Griffeth, US Oncology's National Medical Director for PET and Director of Nuclear Medicine at Baylor University Medical Center. "Furthermore, the results of this trial have confirmed that FDG uptake is generally applicable for tumor assessment in the vast majority of cancers, and that FDG-PET imaging provides crucial additional information in the evaluation of cancer patients -- information that often alters patient care."

In addition to impacting treatment decisions for more than one-third of the treated patients, the study -- which examined 22,975 PET studies performed in 21,419 patients in 1,178 centers nationwide - showed that the use of PET technologies for cancer diagnosis, staging, restaging and recurrence monitoring was associated with a strong reduction in unnecessary additional procedures and helped approximately 70 percent of patients with pre-PET recommended biopsies avoid the procedure as a result of the scan.

"We support Dr. Bruce Hillner's and his colleagues' research on PET scan use in cancer patients, and we hope that CMS takes today's study into account when it considers future National Coverage Decisions for cancer care," said Dr. Griffeth. "It is now time to lift the unnecessary restrictions on the use of PET and to allow the physicians caring for these patients to determine when and how to use this vital tool in oncologic care."

About US Oncology, Inc.

Headquartered in Houston, US Oncology works closely with physicians, manufacturers and payers to enhance patient access to advanced cancer care in the community setting. US Oncology supports the nation's foremost cancer treatment and research network in its efforts to accelerate the availability and use of scientific, evidence-based medicine.

According to the company's last quarterly earnings report, US Oncology is affiliated with 1,164 physicians operating in 443 locations, including 91 radiation oncology facilities in 39 states. For more information, visit the company's Web site, http://www.usoncology.com.


'/>"/>
SOURCE US Oncology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Lilly Oncology to Unveil More Than 50 Studies at ASCO 2008
2. US Oncology Welcomes New Director of Federal Government Relations
3. European Society for Medical Oncology and European CanCer Organization join forces
4. The Rocky Mountain Hospital for Children at Presbyterian/St. Lukes is now Member of the Childrens Oncology Group
5. Ambulatory Services of America, Inc. Announces Joint Venture with Southern Ocean County Radiation Oncology, LLC
6. EUSA Pharma to Acquire US Specialty Oncology Company Cytogen
7. Geriatric Oncology Consortium (GOC) Announces Tampa Bay Road Rally to Raise Awareness for the Treatment of Seniors With Cancer
8. US Oncology to Report 2007 Fourth Quarter and Year-End Earnings Results
9. SearchMedicas Second Quarterly Top Clinical Search Terms Report Reveals Top 25 Oncology, General Medicine and Psychiatry Search Terms Among Medical Professionals
10. Oncology Metrics Launches the National Practice Benchmark: One in a Series of Initiatives to Help Community Oncology Practices Better Measure Operational and Financial Performance
11. Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & Wellness ... Moonlight to raise money for the American Heart Association Heart Walk. Teams of up ... work together to keep their treadmills moving for 5 hours. Treadmills will start at ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
(Date:9/12/2017)... 12, 2017   EcoVadis , the leading platform for environmental, social ... annual edition of its Global CSR Risk and Performance Index. The report ... based on Scorecard Ratings that analyzed nearly 800,000 data points across the ... ... ...
Breaking Medicine Technology: